We are delighted to present the Frontiers in Pharmacology “Women in Gastrointestinal and Hepatic Pharmacology: 2024” series of article collections.
At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Pharmacology is proud to offer this platform to promote the work of women scientists, across all fields of gastrointestinal and hepatic pharmacology.
The work presented here highlights the diversity of research performed across the entire breadth of gastrointestinal and hepatic pharmacology research and presents advances in theory, experiment, and methodology with applications to compelling problems.
This Research Topic is open to submissions that focus on, but is not limited to, the following themes:
• Novel drug targets and therapeutic strategies for gastrointestinal and hepatic disorders
• Mechanisms of drug action and pharmacokinetics in the gastrointestinal tract and liver
• Personalized medicine in gastrointestinal and hepatic diseases
• Drug-induced liver injury and adverse drug reactions
• Emerging technologies and methodologies in pharmacological research related to the gastrointestinal tract and liver
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
Keywords:
#CollectionSeries, Women in Science, Research, Gastrointestinal, Hepatic, Pharmacology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
We are delighted to present the Frontiers in Pharmacology “Women in Gastrointestinal and Hepatic Pharmacology: 2024” series of article collections.
At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Pharmacology is proud to offer this platform to promote the work of women scientists, across all fields of gastrointestinal and hepatic pharmacology.
The work presented here highlights the diversity of research performed across the entire breadth of gastrointestinal and hepatic pharmacology research and presents advances in theory, experiment, and methodology with applications to compelling problems.
This Research Topic is open to submissions that focus on, but is not limited to, the following themes:
• Novel drug targets and therapeutic strategies for gastrointestinal and hepatic disorders
• Mechanisms of drug action and pharmacokinetics in the gastrointestinal tract and liver
• Personalized medicine in gastrointestinal and hepatic diseases
• Drug-induced liver injury and adverse drug reactions
• Emerging technologies and methodologies in pharmacological research related to the gastrointestinal tract and liver
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
Keywords:
#CollectionSeries, Women in Science, Research, Gastrointestinal, Hepatic, Pharmacology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.